• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨曲南在人体前列腺组织中的浓度。

Aztreonam concentrations in human prostatic tissue.

作者信息

Madsen P O, Dhruv R, Friedhoff L T

出版信息

Antimicrob Agents Chemother. 1984 Jul;26(1):20-1. doi: 10.1128/AAC.26.1.20.

DOI:10.1128/AAC.26.1.20
PMID:6383208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC179908/
Abstract

The concentrations of aztreonam in human prostatic tissue specimens obtained by transurethral resection were measured in nine patients after the intramuscular administration of a single 1-g dose. The average concentration of aztreonam was 7.8 microgram/g of prostate between 50 and 180 min after dosage. The average ratio of the drug concentration in prostate to that in serum was 0.25. The concentrations of aztreonam achieved were significantly higher than the MICs for most members of the family Enterobacteriaceae implicated in chronic prostatitis.

摘要

对9例患者单次肌内注射1g剂量氨曲南后,通过经尿道切除术获取的人前列腺组织标本中氨曲南的浓度进行了测定。给药后50至180分钟,氨曲南在前列腺中的平均浓度为7.8微克/克。前列腺中药物浓度与血清中药物浓度的平均比值为0.25。所测得的氨曲南浓度显著高于与慢性前列腺炎相关的大多数肠杆菌科成员的最低抑菌浓度。

相似文献

1
Aztreonam concentrations in human prostatic tissue.氨曲南在人体前列腺组织中的浓度。
Antimicrob Agents Chemother. 1984 Jul;26(1):20-1. doi: 10.1128/AAC.26.1.20.
2
Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.哌拉西林-他唑巴坦在人前列腺组织中的渗透及基于部位特异性药代动力学和药效学的前列腺炎给药考量
J Infect Chemother. 2015 Aug;21(8):575-80. doi: 10.1016/j.jiac.2015.04.015. Epub 2015 May 14.
3
Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.帕珠沙星在前列腺组织中的临床药代动力学及药效学靶点达成情况:前列腺炎的给药考量
J Infect Chemother. 2017 Dec;23(12):809-813. doi: 10.1016/j.jiac.2017.08.005. Epub 2017 Oct 12.
4
Acute prostatitis: which antibiotic to use first.急性前列腺炎:首先应使用哪种抗生素。
J Chemother. 1990 Aug;2(4):244-6. doi: 10.1080/1120009x.1990.11739024.
5
Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.氟罗沙星(Ro 23 - 6240)在犬前列腺组织和体液中的分布。
Antimicrob Agents Chemother. 1987 Jul;31(7):1010-3. doi: 10.1128/AAC.31.7.1010.
6
Penetration of monobactam antibiotics (aztreonam, carumonam) into human prostatic tissue.单环β-内酰胺类抗生素(氨曲南、卡芦莫南)在人前列腺组织中的渗透情况。
Chemotherapy. 1989;35(1):7-11. doi: 10.1159/000238629.
7
[Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
Hinyokika Kiyo. 1985 Mar;31(3):539-43.
8
Clinical pharmacokinetics of flomoxef in prostate tissue and dosing considerations for prostatitis based on site-specific pharmacodynamic target attainment.氟氧头孢在前列腺组织中的临床药代动力学及基于部位特异性药效目标达成度的前列腺炎给药考虑
J Infect Chemother. 2020 Feb;26(2):236-241. doi: 10.1016/j.jiac.2019.08.019. Epub 2019 Dec 9.
9
Aztreonam in human serum and breast milk.氨曲南在人血清和母乳中的情况。
Br J Clin Pharmacol. 1985 Apr;19(4):509-11. doi: 10.1111/j.1365-2125.1985.tb02677.x.
10
Penetration of aztreonam into human bronchial secretions.氨曲南在人支气管分泌物中的渗透情况。
Antimicrob Agents Chemother. 1985 Feb;27(2):263-4. doi: 10.1128/AAC.27.2.263.

引用本文的文献

1
Tissue Distribution and Pharmacokinetic Characteristics of Aztreonam Based on Multi-Species PBPK Model.基于多物种生理药代动力学(PBPK)模型的氨曲南组织分布及药代动力学特征
Pharmaceutics. 2025 Jun 6;17(6):748. doi: 10.3390/pharmaceutics17060748.
2
Clinical pharmacokinetics of aztreonam. An update.氨曲南的临床药代动力学。最新进展。
Clin Pharmacokinet. 1994 Feb;26(2):99-106. doi: 10.2165/00003088-199426020-00003.
3
Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgery.在胸外科和妇科手术期间获取的人体组织中的氨曲南浓度。
Antimicrob Agents Chemother. 1986 Sep;30(3):505-7. doi: 10.1128/AAC.30.3.505.
4
Aztreonam concentration in abdominal tissues and bile.氨曲南在腹部组织和胆汁中的浓度。
Antimicrob Agents Chemother. 1986 Jun;29(6):1101-3. doi: 10.1128/AAC.29.6.1101.
5
Aztreonam penetration into synovial fluid and bone.氨曲南在滑液和骨中的渗透情况。
Antimicrob Agents Chemother. 1986 Apr;29(4):710-2. doi: 10.1128/AAC.29.4.710.
6
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.氨曲南。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.
7
Clinical pharmacokinetics of aztreonam.
Clin Pharmacokinet. 1988 Mar;14(3):148-55. doi: 10.2165/00003088-198814030-00003.

本文引用的文献

1
Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.健康受试者中单环β-内酰胺类氨曲南(SQ 26,776)的单剂量药代动力学。
Antimicrob Agents Chemother. 1982 Jun;21(6):944-9. doi: 10.1128/AAC.21.6.944.
2
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.氨曲南(SQ 26,776),一种对需氧革兰氏阴性菌有特效的合成单环β-内酰胺抗生素。
Antimicrob Agents Chemother. 1982 Jan;21(1):85-92. doi: 10.1128/AAC.21.1.85.
3
The concentration of sulphamethoxazole and trimethoprim in human prostate gland.
Br J Urol. 1975 Jun;47(3):301-4. doi: 10.1111/j.1464-410x.1975.tb03970.x.